|
KYTX Kyverna Therapeutics Inc 1994702 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-38,319,000.00 |
| Balance Sheet |
|
Current Assets
|
$206,542,000.00 |
|
Assets
|
$219,823,000.00 |
|
Current Liabilities
|
$22,802,000.00 |
|
Liabilities
|
$54,274,000.00 |
|
Equity
|
$165,549,000.00 |
|
Shares Out
|
61570247.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-81,903,000.00 |
|
Investing Cash Flow
|
$-14,071,000.00 |
| Market Analysis |
Market Cap
|
$500,566,108.11 |
|
Price
|
$8.13 |
|
BVPS
|
2.69 |
|
PB
|
3.02 |
|
EPS
|
-0.63 |
|
FCF
|
$-82,196,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:39 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:30 |
|
| Apr |
May |
Jun |
| 2026-03-26 |
-0.80 |
|
|
2026-05-12 |
-0.66 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.97 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-0.85 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KYTX documents filed with the SEC.
KYTX Filings
Clear
